Nutrition and Food Security Research Center.
Department of Nutrition, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Adv Nutr. 2019 May 1;10(3):419-432. doi: 10.1093/advances/nmy108.
A number of clinical trials have examined the effect of canola oil (CO) on body composition in recent years; however, the results have been inconsistent. The present investigation aims to examine the effect of CO on body weight (BW) and body composition using a systematic review and meta-analysis of controlled clinical trials. Online databases including PubMed, Scopus, and Google Scholar were searched up to February, 2018 for randomized controlled clinical trials that examined the effect of CO on anthropometric measures and body composition indexes in adults. The Cochrane Collaboration's tool was used to assess the risk of bias in individual studies. A random-effects model was used to evaluate the effect of CO consumption on several outcomes: BW, body mass index, waist circumference, hip circumference, waist-to-hip ratio, android-to-gynoid ratio, and body lean and fat mass. In total, 25 studies were included in the systematic review. The meta-analysis revealed that CO consumption reduces BW [weighted mean difference (WMD) = -0.30 kg; 95% CI: -0.52, -0.08 kg, P = 0.007; n = 23 effect sizes], particularly in participants with type 2 diabetes (WMD = -0.63 kg; 95% CI: -1.09, -0.17 kg, P = 0.007), in studies with a parallel design (WMD = -0.49 kg; 95% CI: -0.85, -0.14 kg, P = 0.006), in nonfeeding trials (WMD = -0.32 kg; 95% CI: -0.55, -0.09 kg, P = 0.006), and when compared with saturated fat (WMD = -0.40 kg; 95% CI: -0.74, -0.06 kg, P = 0.019). CO consumption did not significantly affect any other anthropometric measures or body fat markers (P > 0.05). Although CO consumption results in a modest decrease in BW, no significant effect was observed on other adiposity indexes. Further well-constructed clinical trials that target BW and body composition as their primary outcomes are needed.
近年来,许多临床试验都研究了菜籽油(CO)对人体成分的影响;然而,结果并不一致。本研究旨在通过对对照临床试验的系统评价和荟萃分析,研究 CO 对体重(BW)和身体成分的影响。在线数据库包括 PubMed、Scopus 和 Google Scholar 均检索至 2018 年 2 月,以寻找检查 CO 对成年人人体测量指标和身体成分指标影响的随机对照临床试验。采用 Cochrane 协作组工具评估单个研究的偏倚风险。采用随机效应模型评估 CO 消耗对以下几个结果的影响:BW、体重指数、腰围、臀围、腰臀比、安卓到女性比以及身体瘦体重和脂肪量。共有 25 项研究纳入系统评价。荟萃分析显示,CO 消耗可降低 BW [加权均数差(WMD)=-0.30 kg;95%CI:-0.52,-0.08 kg,P=0.007;n=23 个效应量],尤其是在 2 型糖尿病患者中(WMD=-0.63 kg;95%CI:-1.09,-0.17 kg,P=0.007),在平行设计的研究中(WMD=-0.49 kg;95%CI:-0.85,-0.14 kg,P=0.006),在非喂养试验中(WMD=-0.32 kg;95%CI:-0.55,-0.09 kg,P=0.006),与饱和脂肪相比(WMD=-0.40 kg;95%CI:-0.74,-0.06 kg,P=0.019)。CO 消耗对其他任何人体测量指标或体脂标志物均无显著影响(P>0.05)。尽管 CO 消耗可使 BW 适度下降,但对其他肥胖指数没有观察到显著影响。需要进一步开展以 BW 和身体成分作为主要终点的精心设计的临床试验。